Introduction: Loiasis related post-ivermectin (IVM) adverse events (AEs) hinder lymphatic filariasis (LF)/onchocerciasis elimination in co-endemic areas. Findings from LF suggest that post-IVM AEs might be the result of immune responses to filarial or Wolbachia antigens released by dying microfilariae (Mf). The aim of this study was to determine whether IVM treatment of loiasis, devoid of […]
4. Immunologic Response to Ivermectin Treatment of Loiasis
